Silo Pharma (SILO) Other Working Capital Changes (2023 - 2026)
Silo Pharma (SILO) posted Other Working Capital Changes of -$18025.0 for Q1 2026, little changed sequentially from -$18026.0 in Q4 2025, and little changed YoY from -$18024.0 in Q1 2025.
Silo Pharma (SILO) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Silo Pharma has reported Other Working Capital Changes for 4 years, with the latest figure at -$18025.0 in Q1 2026.
- Quarterly Other Working Capital Changes changed 0.01% year-over-year to -$18025.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$72101.0 (changed 0.0% YoY) and the FY2025 annual result came in at -$72102.0, changed 0.0% from the prior year.
- Other Working Capital Changes was little changed at -$18025.0 in Q1 2026 per SILO's latest filing, from -$18026.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $124706.0 in Q3 2024 and troughed at -$216956.0 in Q4 2024.
- A 5-year average of $7889.1 and a median of -$17321.0 in 2025 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2024 and 2026: Other Working Capital Changes changed 0.0% in 2024, then gained 0.01% in 2026.
- Over 4 years, Other Working Capital Changes stood at -$18026.0 in 2023, then changed by 0.0% to -$18026.0 in 2024, then changed by 0.0% to -$18026.0 in 2025, then advanced by 0.01% to -$18025.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$18025.0, -$18026.0, and -$18025.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Silo Pharma | 3.04 Mn | 3.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.00 |
| Jun 30, 2026 | -1.00 |
| Jun 30, 2026 | -1.00 |
| Mar 31, 2026 | -18,025.00 |
| Mar 31, 2026 | -18,025.00 |
| Mar 31, 2026 | -18,025.00 |
| Dec 31, 2025 | -18,026.00 |
| Dec 31, 2025 | -18,026.00 |
| Dec 31, 2025 | -18,026.00 |
| Sep 30, 2025 | -18,025.00 |
| Sep 30, 2025 | -18,025.00 |
| Sep 30, 2025 | -18,025.00 |
| Jun 30, 2025 | -18,025.00 |
| Jun 30, 2025 | -18,025.00 |
| Jun 30, 2025 | -18,025.00 |
| Mar 31, 2025 | -18,026.00 |
| Mar 31, 2025 | -18,026.00 |
| Mar 31, 2025 | -18,026.00 |
| Dec 31, 2024 | -18,026.00 |
| Dec 31, 2024 | -18,026.00 |